Characterization of envelope function of transmitted viruses circulating in Mbeya, Tanzania, and its impact on disease progression

by Nofemela A, Bandawe G, Thebus R, Marais J, Maboko L, Hoelscher M, Williamson C, Woodman Z
Published 2012-09-01

Pattern of HIV risk behavior in a cohort of high risk women in East Africa

by Kibuuka HN, Rono K, Maganga L, Millard M, Sekiziyivu A, Maboko L, Shaffer D, Valenzuela A, Michael N, Robb M
Published 2012-09-01

High prevalence of ECG variations and abnormalities in young and healthy TaMoVac 01 HIV vaccine trial volunteers from Tanzania

by Mann PJ, Munseri P, Kaluwa B, Missanga M, Lwakatare J, Hoelscher M, Bakari M, Janabi M, Maboko L, Sandström E, Kroidl A
Published 2012-09-01

S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania

by McCutchan FE, Michael NL, Robb ML, Hoelscher M, Maboko L, Ratto-Kim S, Moqueet N, Bautista CT, Currier JR, Saathoff E, Walsh AM, Koehler RN, Kim JH, Kijak GH
Published 2009-10-01

P08-03. Genetic complexity of TRIM5 and APOBEC in East Africa

by Michael NL, Robb ML, Wabwire-Mangen F, Maboko L, Hoelscher M, Kibuuka H, Eller M, Eller L, Bautista C, Moqueet N, Koehler R, Perret K, Walsh AM, McCutchan F, Kim J, Kijak GH
Published 2009-10-01

Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime

by Bauer A, Podola L, Haule A, Sudi L, Nilsson C, Mann P, Missanga M, Kaluwa B, Maboko L, Lueer C, Mwakatima M, Aboud S, Bakari M, Currier J, Robb M, Joseph S, McCormack S, Lyamuya E, Wahren B, Sandström E, Biberfeld G, Hoelscher M, Kroidl A, Geldmacher C
Published 2012-09-01

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen

by Podola L, Bauer A, Haule A, Sudi L, Nilsson C, Godoy-Ramirez K, Mann P, Missanga M, Kaluwa B, Maboko L, Lueer C, Mwakatima M, Aboud S, Bakari M, Currier J, Robb M, McCormack S, Joseph S, Lyamuya E, Hoelscher M, Wahren B, Sandström E, Biberfeld G, Geldmacher C, Kroidl A
Published 2012-09-01

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine

by Munseri P, Kroidl A, Nilsson C, Moshiro C, Aboud S, Joachim A, Geldmacher C, Aris E, Buma D, Lyamuya E, Gotch F, Godoy-Ramirez K, Pallangyo K, Maboko L, Marovich M, Robb M, Hoelscher M, Janabi M, Mann P, Joseph S, Mfinanga S, Stoehr W, Mhalu F, Wahren B, Biberfeld G, McCormack S, Sandstrom E, Bakari M
Published 2012-09-01